Skip to content

Comorbidities and Outcomes in Early Rheumatoid Arthritis

The Epidemiology of Cardiovascular Disease, Haematological Abnormalities, and Other Comorbidities in Early Rheumatoid Arthritis in the United Kingdom and Their Associations With Important Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03675516
Enrollment
13182
Registered
2018-09-18
Start date
2004-03-01
Completion date
2017-01-01
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Identify the burden of comorbidity at the time of diagnosis of rheumatoid arthritis. Identify the impact of comorbidity present at diagnosis on cardiovascular disease, death, rheumatoid arthritis disease progression and infections.

Interventions

Sponsors

Momentum Data
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of rheumatoid arthritis prior to 1st January 2017 * Aged ≥18 years old

Exclusion criteria

* Patients with another other rheumatic disease

Design outcomes

Primary

MeasureTime frameDescription
Event Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart FailureFrom the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of myocardial infarction, stroke, or heart failure (whichever came first) or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).
Event Rate for a Composite of Incident Infections.From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of infection or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).The composite will comprise incident upper respiratory tract infections, bronchitis, influenza-like illnesses, pneumonia, intestinal infectious diseases, herpes simplex, skin and soft tissue infections, urinary tract infections, and genital and perineal infections

Secondary

MeasureTime frame
Event Rate for Incident StrokeFrom the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of stroke or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).
Event Rate for Incident Heart FailureFrom the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of heart failure or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).
Event Rate for a Joint Operations Composite, Comprised of Incident Joint Operations on Shoulder, Elbow, Wrist, Hand, Hip, Knee, Ankle and FootFrom the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of joint operation to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Rheumatoid Arthritis Cases
New onset cases of rheumatoid arthritis No specific intervention: Usual care
6,591
Controls
Age, gender and primary care practice-matched controls No specific intervention: Usual care
6,591
Total13,182

Baseline characteristics

CharacteristicControlsTotalRheumatoid Arthritis Cases
Age, Continuous59.8 years
STANDARD_DEVIATION 15.8
59.8 years
STANDARD_DEVIATION 15.8
59.8 years
STANDARD_DEVIATION 15.8
Race/Ethnicity, Customized
Asian
174 Participants429 Participants255 Participants
Race/Ethnicity, Customized
Black
125 Participants253 Participants128 Participants
Race/Ethnicity, Customized
Missing
1819 Participants3082 Participants1263 Participants
Race/Ethnicity, Customized
Mixed
24 Participants50 Participants26 Participants
Race/Ethnicity, Customized
Other
21 Participants57 Participants36 Participants
Race/Ethnicity, Customized
White
4428 Participants9311 Participants4883 Participants
Region of Enrollment
United Kingdom
6591 participants13182 participants6591 participants
Sex: Female, Male
Female
4449 Participants8898 Participants4449 Participants
Sex: Female, Male
Male
2142 Participants4284 Participants2142 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 6,5910 / 6,591
other
Total, other adverse events
0 / 6,5910 / 6,591
serious
Total, serious adverse events
0 / 6,5910 / 6,591

Outcome results

Primary

Event Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart Failure

Time frame: From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of myocardial infarction, stroke, or heart failure (whichever came first) or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

ArmMeasureValue (NUMBER)
Rheumatoid Arthritis CasesEvent Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart Failure10.62 Events per 1000 person years
ControlsEvent Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart Failure8.13 Events per 1000 person years
Primary

Event Rate for a Composite of Incident Infections.

The composite will comprise incident upper respiratory tract infections, bronchitis, influenza-like illnesses, pneumonia, intestinal infectious diseases, herpes simplex, skin and soft tissue infections, urinary tract infections, and genital and perineal infections

Time frame: From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of infection or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

Population: This outcome was not assessed in controls

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rheumatoid Arthritis CasesEvent Rate for a Composite of Incident Infections.3506 Participants
ControlsEvent Rate for a Composite of Incident Infections.0 Participants
Secondary

Event Rate for a Joint Operations Composite, Comprised of Incident Joint Operations on Shoulder, Elbow, Wrist, Hand, Hip, Knee, Ankle and Foot

Time frame: From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of joint operation to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

Population: A comparison with controls was not included for this endpoint as this end point was only relevant to people with rheumatoid arthritis (as a marker of disease severity) and was not collected for controls.

ArmMeasureValue (NUMBER)
Rheumatoid Arthritis CasesEvent Rate for a Joint Operations Composite, Comprised of Incident Joint Operations on Shoulder, Elbow, Wrist, Hand, Hip, Knee, Ankle and Foot20.11 Events per 1000 person years
Secondary

Event Rate for Incident Heart Failure

Time frame: From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of heart failure or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

ArmMeasureValue (NUMBER)
Rheumatoid Arthritis CasesEvent Rate for Incident Heart Failure3.98 Events per 1000 person years
ControlsEvent Rate for Incident Heart Failure2.72 Events per 1000 person years
Secondary

Event Rate for Incident Stroke

Time frame: From the date of rheumatoid arthritis diagnosis (after 1st January 2004) to the date of diagnosis of stroke or to loss to follow-up or until 1st January 2017 (maximum follow-up: 13 years).

ArmMeasureValue (NUMBER)
Rheumatoid Arthritis CasesEvent Rate for Incident Stroke4.29 Events per 1000 person years
ControlsEvent Rate for Incident Stroke3.82 Events per 1000 person years

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026